MIRA INFORM REPORT

 

 

Report Date :

23.03.2013

 

IDENTIFICATION DETAILS

 

Name :

ZIEMER OPHTHALMIC SYSTEMS AG

 

 

Registered Office :

Allmendstrasse 11, 2562 Port/BE

 

 

Country :

Switzerland

 

 

Date of Incorporation :

10.10.2003

 

 

Com. Reg. No.:

Company limited by shares

 

 

Legal Form :

073.3.015.345-9 / 721211

 

 

Line of Business :

The Company develops and markets products from the fields of ophthalmology, ophthalmic surgery, ocular diagnostics and microtechnology

 

 

No. of Employees :

60

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory 

 

 

Payment Behaviour :

Regular 

 

 

Litigation :

Clear 

 


NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30th, 2012

 

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

Switzerland

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

Switzerland - ECONOMIC OVERVIEW

 

Switzerland is a peaceful, prosperous, and modern market economy with low unemployment, a highly skilled labor force, and a per capita GDP among the highest in the world. Switzerland's economy benefits from a highly developed service sector, led by financial services, and a manufacturing industry that specializes in high-technology, knowledge-based production. Its economic and political stability, transparent legal system, exceptional infrastructure, efficient capital markets, and low corporate tax rates also make Switzerland one of the world's most competitive economies. The Swiss have brought their economic practices largely into conformity with the EU's, to enhance their international competitiveness, but some trade protectionism remains, particularly for its small agricultural sector. The fate of the Swiss economy is tightly linked to that of its neighbors in the euro zone, which purchases half of all Swiss exports. The global financial crisis of 2008 and resulting economic downturn in 2009 stalled export demand and put Switzerland in a recession. The Swiss National Bank (SNB) during this period effectively implemented a zero-interest rate policy to boost the economy as well as prevent appreciation of the franc, and Switzerland's economy recovered in 2010 with 2.7% growth. The sovereign debt crises currently unfolding in neighboring euro-zone countries pose a significant risk to Switzerland's financial stability and are driving up demand for the Swiss franc by investors seeking a safehaven currency. The independent SNB has upheld its zero-interest rate policy and conducted major market interventions to prevent further appreciation of the Swiss franc, but parliamentarians have urged it to do more to weaken the currency. The franc's strength has made Swiss exports less competitive and weakened the country's growth outlook; GDP growth fell to 2.1% in 2011. Switzerland has also come under increasing pressure from individual neighboring countries, the EU, the US, and international institutions to reform its banking secrecy laws. Consequently, the government agreed to conform to OECD regulations on administrative assistance in tax matters, including tax evasion. The government has renegotiated its double taxation agreements with numerous countries, including the US, to incorporate the OECD standard, and in 2011 it reached deals with Germany and the UK to resolve outstanding issues, particularly the possibility of imposing taxes on bank deposits held by foreigners. These steps will have a lasting impact on Switzerland's long history of bank secrecy.

 

Source : CIA

 

 


Company name

 

Ziemer Ophthalmic Systems AG

 

Operating address

 

Allmendstrasse 11

2562 Port/BE

Switzerland/CH

Telephone:                   032 3327050

Fax:                             032 3327071

Web site:                      http://www.ziemergroup.com

E-mail:                         innovation@ziemergroup.com

VAT-No.:                      CHE110254181

 

 

Profile

 

Established:                 2003

Line of Business:          Consumer goods wholesale, Pharmaceutics

Industry Division:          Wholesale trade, Services

Industry-code (NACE):     4646     Wholesale of pharmaceutical goods

                                      7219     Other research and experimental development on natural sciences and engineering

Import/Export:              Export

Banks:                          unknown

 

 

Operational Figures

 

Coverage:                    Company

Figures:                        estimated

Employees:                  60

 

 

Activity

 

The Company develops and markets products from the fields of ophthalmology, ophthalmic surgery, ocular diagnostics and microtechnology.

 

 


Real Estate

 

Information on property ownership was not available.

 

 

Company Register

 

Company No:               073.3.015.345-9 / 721211

Legal form:                   Company limited by shares

Registration:                 10.10.2003

Legal status:                 active

Responsible Register:   Handelsregister des Kantons Bern

History:                        Date of Incorporation Statutes: 17.09.2003

 

Entry            Deleted    Name

10.10.2003                    Ziemer Ophthalmic Systems AG

 

Entry            Deleted    Legal domicile

10.10.2003                    Port, Switzerland

 

Entry            Deleted    Address

07.11.2003                    Allmendstrasse 11, 2562 Port/BE, Switzerland/CH

 

Entry            Deleted    Capital

10.10.2003                    Share Capital CHF 100'000, paidup CHF 100'000

 

Entry            Deleted    Capital Structure

10.10.2003                    100 Registered shares of CHF 1'000.--

 

Entry            Deleted    Activity (original Language)

10.10.2003                    Entwicklung, Verkauf, Vertrieb von technisch hochstehenden Produkten im Bereich Medizinaltechnik und der Ophthalmologie im weitesten Sinne. Die Gesellschaft kann Liegenschaften erwerben und veräussern.

 

Entry            Deleted    Remarks (original Language)

10.10.2003                    Publishing authority: SHAB.

10.10.2003                    Shares: Die Übertragbarkeit der Namenaktien ist nach Massgabe der Statuten beschränkt.

10.10.2003                    Reports:            Mitteilungen an die Aktionäre: schriftlich via Briefpost oder per E-Mail.

 

 

Official Administration

 

Title                                           Name

President                                    Kurt Ziemer, Origin: Port, Switzerland, Residential address: 2562 Port, Switzerland, joint signature of two, Registered since: 10.10.2003

Director                                      Frank Ziemer, Origin: Port, Switzerland, Residential address: 2563 Ipsach, Switzerland, joint signature of two, Registered since: 10.10.2003

Management

 

Title                                           Name

Member with signing authority     Hansjörg Adam, Origin: Schlosswil, Switzerland, Residential address: 5102 Rupperswil, Switzerland, joint signature of two, Registered since: 12.10.2010

Member with signing authority     Urs Habermacher, Origin: Rickenbach LU, Switzerland, Residential address: 3210 Kerzers, Switzerland, joint signature of two, Registered since: 06.01.2010

Member with signing authority     Hartmut Kanngiesser, Origin: Germany, Residential address: 8000 Zürich, Switzerland, joint signature of two, Registered since: 12.10.2010

Member with signing authority     Sandro Palumbo, Origin: Langnau im Emmental, Switzerland, Residential address: 3003 Bern, Switzerland, joint signature of two, Registered since: 12.10.2010

Member with signing authority     Christian Rathjen, Origin: Germany, Residential address: Ferney-Voltaire , France, joint signature of two, Registered since: 12.10.2010

Member with signing authority     Hansjörg Riedwyl, Origin: Kehrsatz, Switzerland, Residential address: 2500 Biel/Bienne, Switzerland, joint signature of two, Registered since: 12.10.2010

Member with signing authority     Alexander Seibold, Origin: Germany, Residential address: Lörrach , Germany, joint signature of two, Registered since: 15.02.2013

Member with signing authority     Fritz Adrian Weibel, Origin: Sursee, Malters, Switzerland, Residential address: Avry-sur-Matran, Switzerland, joint signature of two, Registered since: 01.03.2013

 

 

External Positions

 

Title                                           Name

Auditor                                       BDO AG, Residential address: Bern, Switzerland, Id: CH-035-9.003.690-9, Registered since: 31.08.2006

 

 

Executive board

 

Title                                           Name

Chief Executive Officer               Frank Ziemer

 

 

Ultimate Parent Company

 

Name:                          Ziemer Group AG

City/Country:                Port/BE, Switzerland/CH

 

 

Owner/-s

 

No. of Owner/-s:           1

Owner:                         The company is domestic owned.

 

Class:                          100%

Name:                          Ziemer Group AG

City/Country:                Port/BE, Switzerland/CH

Interest:                        100.00% voting right, 100.00% capital interest

 

 

Sisters

 

Name:                          Adoptics AG in Liquidation

City/Country:                Brügg bei Biel/BE, Switzerland/CH

 

Name:                          GZK Immobilien AG

City/Country:                Port/BE, Switzerland/CH

 

Name:                          Meichtry Revisions AG

City/Country:                Biel/Bienne/BE, Switzerland/CH

 

Name:                          SGA Graphite AG

City/Country:                Port/BE, Switzerland/CH

 

Name:                          SIE AG, Surgical Instrument Engineering

City/Country:                Port/BE, Switzerland/CH

 

Name:                          SIS AG, Surgical Instrument Systems

City/Country:                Port/BE, Switzerland/CH

 

Name:                          SMB (Swiss Medical Blade) AG

City/Country:                Port/BE, Switzerland/CH

 

Name:                          SMT Swiss Microtechnology AG

City/Country:                Port/BE, Switzerland/CH

 

 

Investments

 

It is believed that the company has no investments.

 

 

Legal Actions

 

Control date       Year                       No.             Amount CHF     Status

08.09.2011          2011                           0

08.09.2011          2010                           0

08.09.2011          2009                           0

08.09.2011          2008                           1                         84'438.--       Legal actions

 

An updated legal action check is only available against proof of interest. e.g. a copy of an enquiry letter, and order or invoice relating to the subject company.

 

 

Credit Information

 

Financial Statements:    The company does not disclose any financial statements. Third parties are not permitted any insight into the financial affairs. It is therefore difficult to make a proper assessment of the actual situation.

 

Financial Situation:        The financial situation is in order.

 

Payment experiences:   Financial obligations are met as appropriate.

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.54.34

UK Pound

1

Rs.82.56

Euro

1

Rs.70.10

 

INFORMATION DETAILS

 

Report Prepared by :

MNL

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.